“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

A study of rhesus macaques revealed that infants who experienced higher levels of maltreatment by their mothers tended to ...

Methods: A retrospective drug utilization evaluation was conducted in patients who received levodopa or dopamine agonist for RLS from July 1, 2006, to July 31, 2007. Patients' medical records were ...

According to GlobalData’s Drugs Database, the schizophrenia market remains dominated by dopamine-targeted mechanisms, such as ...

Bromocriptine is unique in that it does not have a specific receptor that mediates its action on glucose and lipid metabolism. Rather, its effects are mediated via resetting of dopaminergic and ...

Tavapadon hit the primary endpoint in one phase 3 trial in April, before AbbVie closed the takeover, and racked up another victory in September. AbbVie completed the set Monday by reporting data from ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

However, his GP did not inform him about the drug's potential side effects, which include impulse control disorders such as ...

treated with dopamine agonists (DAs). The main aim of this study was to analyse ICD prevalence with different DAs. Methods We carried out a multicentre transversal study to evaluate the presence of ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

Electronic devices give us plenty of enjoyment nowadays, but Dr. Alok Kinojia says this has "raised the bar" for what it ...